" /> Response to neoadjuvant therapy:PrThr:Pt:Colorectal cancer specimen:Ord: - CISMeF





Preferred Label : Response to neoadjuvant therapy:PrThr:Pt:Colorectal cancer specimen:Ord:;

LOINC status : ACTIVE;

LOINC display name : Response to neoadjuvant therapy Ql (Colorectal cancer specimen);

LOINC long common name : Tumor response to neoadjuvant therapy;

LOINC short name : Tumor resp to neoadjvt therapy;

LOINC description : The response of the tumor to neoadjuvant treatment, such as chemotherapy and radiotherapy. Chemotherapy and/or radiotherapy before resection is associated with significant downstaging and improved prognosis. These specimens require close gross examination and additional blocking to demonstrate tumor. The degree of tumor regression has been shown to correlate with prognosis. This term was created for, but not limited in use to, the Colorectal Cancer Structured Reporting Protocol (2nd Edition, 2012) developed by the Royal College of Pathologists of Australasia (RCPA).;

Détails


Vous pouvez consulter :


Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.